Skip to main content

Closed

JNJ: Johnson & Johnson Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+6.0% / yr

Operating margin26.8%

ROIC13.9%

Financially safe

Strong

Debt / equity0.58×

Interest coverage33.1×

Current ratio1.09×

Valuation

Unrated

P/E ratio30.8×

Dividend yield2.0%

Johnson & Johnson

JNJNew York Stock Exchange·USD·Closed

Johnson & Johnson

JNJNew York Stock Exchange·USD·Closed

$256.35

+0.21%

$256.35

+$0.53 (0.21%)

52W Range

83thpctl

Volume

0.55×avg

Mkt Cap

617.78BUSD

P/E

30.8TTM

Div Yield

1.96%ann

52W Range

83thpctl

Volume

0.55×avg

Market Cap

617.78BUSD

P/E Ratio

30.8TTM

Div Yield

1.96%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings